APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha-1-Antitrypsin Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Alpha-1-Antitrypsin Antibody Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchAlpha-1-Antitrypsin Antibody Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha-1-Antitrypsin Antibody Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Alpha-1-Antitrypsin Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha-1-Antitrypsin Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha-1-Antitrypsin Antibody Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alpha-1-Antitrypsin Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Alpha-1-Antitrypsin Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Alpha-1-Antitrypsin Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Alpha-1-Antitrypsin Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Alpha-1-Antitrypsin Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Alpha-1-Antitrypsin Antibody include Abcam, Abnova, Boster Biological Technology, Creative Biolabs, Creative Diagnostics, G Biosciences, LSBio, NSJ Bioreagents and Santa Cruz Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Alpha-1-Antitrypsin Antibody, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Alpha-1-Antitrypsin Antibody, also provides the revenue of main regions and countries. Of the upcoming market potential for Alpha-1-Antitrypsin Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alpha-1-Antitrypsin Antibody revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alpha-1-Antitrypsin Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Alpha-1-Antitrypsin Antibody revenue, projected growth trends, production technology, application and end-user industry.

Alpha-1-Antitrypsin Antibody Segment by Company

Abcam

Abnova

Boster Biological Technology

Creative Biolabs

Creative Diagnostics

G Biosciences

LSBio

NSJ Bioreagents

Santa Cruz Biotechnology

Signalway Antibody LLC

United States Biological

Merck

Thermo Fisher Scientific

Alpha-1-Antitrypsin Antibody Segment by Type

Polyclonal

Monoclonal

Alpha-1-Antitrypsin Antibody Segment by Application

Immunohistochemistry Frozen

Enzyme Linked Immunosorbent Assay

Western Blot

Others

Alpha-1-Antitrypsin Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-1-Antitrypsin Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha-1-Antitrypsin Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-1-Antitrypsin Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Alpha-1-Antitrypsin Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Alpha-1-Antitrypsin Antibody company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alpha-1-Antitrypsin Antibody revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alpha-1-Antitrypsin Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Polyclonal Major Player Table 3. Monoclonal Major Player Table 4. Global Alpha-1-Antitrypsin Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Immunohistochemistry Frozen Major Player Table 6. Enzyme Linked Immunosorbent Assay Major Player Table 7. Western Blot Major Player Table 8. Others Major Player Table 9. Alpha-1-Antitrypsin Antibody Industry Trends Table 10. Alpha-1-Antitrypsin Antibody Industry Drivers Table 11. Alpha-1-Antitrypsin Antibody Industry Opportunities and Challenges Table 12. Alpha-1-Antitrypsin Antibody Industry Restraints Table 13. Global Alpha-1-Antitrypsin Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Alpha-1-Antitrypsin Antibody Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Alpha-1-Antitrypsin Antibody Market Share by Region (2021-2026) Table 16. Global Alpha-1-Antitrypsin Antibody Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Alpha-1-Antitrypsin Antibody Market Share by Region (2027-2032) Table 18. Global Alpha-1-Antitrypsin Antibody Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Players (2021-2026) Table 20. Global Alpha-1-Antitrypsin Antibody Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Alpha-1-Antitrypsin Antibody Key Players Headquarters & Area Served Table 22. Global Alpha-1-Antitrypsin Antibody Players, Product Type & Application Table 23. Global Alpha-1-Antitrypsin Antibody Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Alpha-1-Antitrypsin Antibody by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Alpha-1-Antitrypsin Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Type (2021-2026) Table 30. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Type (2027-2032) Table 31. Global Alpha-1-Antitrypsin Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Application (2021-2026) Table 35. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Application (2027-2032) Table 36. Abcam Company Information Table 37. Abcam Business Overview Table 38. Abcam Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abcam Alpha-1-Antitrypsin Antibody Product Portfolio Table 40. Abcam Recent Development Table 41. Abnova Company Information Table 42. Abnova Business Overview Table 43. Abnova Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Abnova Alpha-1-Antitrypsin Antibody Product Portfolio Table 45. Abnova Recent Development Table 46. Boster Biological Technology Company Information Table 47. Boster Biological Technology Business Overview Table 48. Boster Biological Technology Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Boster Biological Technology Alpha-1-Antitrypsin Antibody Product Portfolio Table 50. Boster Biological Technology Recent Development Table 51. Creative Biolabs Company Information Table 52. Creative Biolabs Business Overview Table 53. Creative Biolabs Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Creative Biolabs Alpha-1-Antitrypsin Antibody Product Portfolio Table 55. Creative Biolabs Recent Development Table 56. Creative Diagnostics Company Information Table 57. Creative Diagnostics Business Overview Table 58. Creative Diagnostics Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Creative Diagnostics Alpha-1-Antitrypsin Antibody Product Portfolio Table 60. Creative Diagnostics Recent Development Table 61. G Biosciences Company Information Table 62. G Biosciences Business Overview Table 63. G Biosciences Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. G Biosciences Alpha-1-Antitrypsin Antibody Product Portfolio Table 65. G Biosciences Recent Development Table 66. LSBio Company Information Table 67. LSBio Business Overview Table 68. LSBio Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. LSBio Alpha-1-Antitrypsin Antibody Product Portfolio Table 70. LSBio Recent Development Table 71. NSJ Bioreagents Company Information Table 72. NSJ Bioreagents Business Overview Table 73. NSJ Bioreagents Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NSJ Bioreagents Alpha-1-Antitrypsin Antibody Product Portfolio Table 75. NSJ Bioreagents Recent Development Table 76. Santa Cruz Biotechnology Company Information Table 77. Santa Cruz Biotechnology Business Overview Table 78. Santa Cruz Biotechnology Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Santa Cruz Biotechnology Alpha-1-Antitrypsin Antibody Product Portfolio Table 80. Santa Cruz Biotechnology Recent Development Table 81. Signalway Antibody LLC Company Information Table 82. Signalway Antibody LLC Business Overview Table 83. Signalway Antibody LLC Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Signalway Antibody LLC Alpha-1-Antitrypsin Antibody Product Portfolio Table 85. Signalway Antibody LLC Recent Development Table 86. United States Biological Company Information Table 87. United States Biological Business Overview Table 88. United States Biological Alpha-1-Antitrypsin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. United States Biological Alpha-1-Antitrypsin Antibody Product Portfolio Table 90. United States Biological Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Alpha-1-Antitrypsin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck Alpha-1-Antitrypsin Antibody Product Portfolio Table 95. Merck Recent Development Table 96. Thermo Fisher Scientific Company Information Table 97. Thermo Fisher Scientific Business Overview Table 98. Thermo Fisher Scientific Alpha-1-Antitrypsin Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Thermo Fisher Scientific Alpha-1-Antitrypsin Antibody Product Portfolio Table 100. Thermo Fisher Scientific Recent Development Table 101. North America Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Alpha-1-Antitrypsin Antibody Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Alpha-1-Antitrypsin Antibody Revenue by Country (US$ Million) & (2027-2032) Table 115. China Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 116. China Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 117. China Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 118. China Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Alpha-1-Antitrypsin Antibody Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Alpha-1-Antitrypsin Antibody Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Alpha-1-Antitrypsin Antibody Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Alpha-1-Antitrypsin Antibody Image Figure 2. Global Alpha-1-Antitrypsin Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha-1-Antitrypsin Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Polyclonal Image Figure 5. Monoclonal Image Figure 6. Global Alpha-1-Antitrypsin Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Alpha-1-Antitrypsin Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 8. Immunohistochemistry Frozen Image Figure 9. Enzyme Linked Immunosorbent Assay Image Figure 10. Western Blot Image Figure 11. Others Image Figure 12. Global Alpha-1-Antitrypsin Antibody Market Size (US$ Million) & (2021-2032) Figure 13. Global Alpha-1-Antitrypsin Antibody Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Alpha-1-Antitrypsin Antibody Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Alpha-1-Antitrypsin Antibody Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Alpha-1-Antitrypsin Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Alpha-1-Antitrypsin Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Type (2021-2032) Figure 20. Global Alpha-1-Antitrypsin Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Application (2021-2032) Figure 23. North America Alpha-1-Antitrypsin Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032) Figure 25. North America Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032) Figure 26. North America Alpha-1-Antitrypsin Antibody Revenue Share by Country (2021-2032) Figure 27. United States Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Alpha-1-Antitrypsin Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032) Figure 32. Europe Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032) Figure 33. Europe Alpha-1-Antitrypsin Antibody Revenue Share by Country (2021-2032) Figure 34. Germany Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Alpha-1-Antitrypsin Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032) Figure 44. China Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032) Figure 45. Asia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032) Figure 47. Asia Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032) Figure 48. Asia Alpha-1-Antitrypsin Antibody Revenue Share by Region (2021-2032) Figure 49. Japan Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Alpha-1-Antitrypsin Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032) Figure 57. SAMEA Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032) Figure 58. SAMEA Alpha-1-Antitrypsin Antibody Revenue Share by Country (2021-2032) Figure 59. Brazil Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Alpha-1-Antitrypsin Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry Frozen
  • Enzyme Linked Immunosorbent Assay
  • Western Blot
  • Others
Companies covered
  • Abcam
  • Abnova
  • Boster Biological Technology
  • Creative Biolabs
  • Creative Diagnostics
  • G Biosciences
  • LSBio
  • NSJ Bioreagents
  • Santa Cruz Biotechnology
  • Signalway Antibody LLC
  • United States Biological
  • Merck
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alpha-1-Antitrypsin Antibody Market by Type
  3. 1.2.1 Global Alpha-1-Antitrypsin Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Polyclonal
  5. 1.2.3 Monoclonal
  6. 1.3 Alpha-1-Antitrypsin Antibody Market by Application
  7. 1.3.1 Global Alpha-1-Antitrypsin Antibody Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Immunohistochemistry Frozen
  9. 1.3.3 Enzyme Linked Immunosorbent Assay
  10. 1.3.4 Western Blot
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Alpha-1-Antitrypsin Antibody Market Dynamics
  1. 2.1 Alpha-1-Antitrypsin Antibody Industry Trends
  2. 2.2 Alpha-1-Antitrypsin Antibody Industry Drivers
  3. 2.3 Alpha-1-Antitrypsin Antibody Industry Opportunities and Challenges
  4. 2.4 Alpha-1-Antitrypsin Antibody Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Alpha-1-Antitrypsin Antibody Market Perspective (2021-2032)
  2. 3.2 Global Alpha-1-Antitrypsin Antibody Growth Trends by Region
  3. 3.2.1 Global Alpha-1-Antitrypsin Antibody Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alpha-1-Antitrypsin Antibody Market Size by Region (2021-2026)
  5. 3.2.3 Global Alpha-1-Antitrypsin Antibody Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Alpha-1-Antitrypsin Antibody Revenue by Players
  2. 4.1.1 Global Alpha-1-Antitrypsin Antibody Revenue by Players (2021-2026)
  3. 4.1.2 Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Alpha-1-Antitrypsin Antibody Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alpha-1-Antitrypsin Antibody Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Alpha-1-Antitrypsin Antibody Key Players Headquarters & Area Served
  7. 4.4 Global Alpha-1-Antitrypsin Antibody Players, Product Type & Application
  8. 4.5 Global Alpha-1-Antitrypsin Antibody Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Alpha-1-Antitrypsin Antibody Market CR5 and HHI
  11. 4.6.3 2025 Alpha-1-Antitrypsin Antibody Tier 1, Tier 2, and Tier 3
5 Alpha-1-Antitrypsin Antibody Market Size by Type
  1. 5.1 Global Alpha-1-Antitrypsin Antibody Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 5.3 Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Type (2021-2032)
6 Alpha-1-Antitrypsin Antibody Market Size by Application
  1. 6.1 Global Alpha-1-Antitrypsin Antibody Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  3. 6.3 Global Alpha-1-Antitrypsin Antibody Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abcam
  2. 7.1.1 Abcam Company Information
  3. 7.1.2 Abcam Business Overview
  4. 7.1.3 Abcam Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abcam Alpha-1-Antitrypsin Antibody Product Portfolio
  6. 7.1.5 Abcam Recent Developments
  7. 7.2 Abnova
  8. 7.2.1 Abnova Company Information
  9. 7.2.2 Abnova Business Overview
  10. 7.2.3 Abnova Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abnova Alpha-1-Antitrypsin Antibody Product Portfolio
  12. 7.2.5 Abnova Recent Developments
  13. 7.3 Boster Biological Technology
  14. 7.3.1 Boster Biological Technology Company Information
  15. 7.3.2 Boster Biological Technology Business Overview
  16. 7.3.3 Boster Biological Technology Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boster Biological Technology Alpha-1-Antitrypsin Antibody Product Portfolio
  18. 7.3.5 Boster Biological Technology Recent Developments
  19. 7.4 Creative Biolabs
  20. 7.4.1 Creative Biolabs Company Information
  21. 7.4.2 Creative Biolabs Business Overview
  22. 7.4.3 Creative Biolabs Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biolabs Alpha-1-Antitrypsin Antibody Product Portfolio
  24. 7.4.5 Creative Biolabs Recent Developments
  25. 7.5 Creative Diagnostics
  26. 7.5.1 Creative Diagnostics Company Information
  27. 7.5.2 Creative Diagnostics Business Overview
  28. 7.5.3 Creative Diagnostics Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Diagnostics Alpha-1-Antitrypsin Antibody Product Portfolio
  30. 7.5.5 Creative Diagnostics Recent Developments
  31. 7.6 G Biosciences
  32. 7.6.1 G Biosciences Company Information
  33. 7.6.2 G Biosciences Business Overview
  34. 7.6.3 G Biosciences Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  35. 7.6.4 G Biosciences Alpha-1-Antitrypsin Antibody Product Portfolio
  36. 7.6.5 G Biosciences Recent Developments
  37. 7.7 LSBio
  38. 7.7.1 LSBio Company Information
  39. 7.7.2 LSBio Business Overview
  40. 7.7.3 LSBio Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  41. 7.7.4 LSBio Alpha-1-Antitrypsin Antibody Product Portfolio
  42. 7.7.5 LSBio Recent Developments
  43. 7.8 NSJ Bioreagents
  44. 7.8.1 NSJ Bioreagents Company Information
  45. 7.8.2 NSJ Bioreagents Business Overview
  46. 7.8.3 NSJ Bioreagents Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NSJ Bioreagents Alpha-1-Antitrypsin Antibody Product Portfolio
  48. 7.8.5 NSJ Bioreagents Recent Developments
  49. 7.9 Santa Cruz Biotechnology
  50. 7.9.1 Santa Cruz Biotechnology Company Information
  51. 7.9.2 Santa Cruz Biotechnology Business Overview
  52. 7.9.3 Santa Cruz Biotechnology Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Santa Cruz Biotechnology Alpha-1-Antitrypsin Antibody Product Portfolio
  54. 7.9.5 Santa Cruz Biotechnology Recent Developments
  55. 7.10 Signalway Antibody LLC
  56. 7.10.1 Signalway Antibody LLC Company Information
  57. 7.10.2 Signalway Antibody LLC Business Overview
  58. 7.10.3 Signalway Antibody LLC Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Signalway Antibody LLC Alpha-1-Antitrypsin Antibody Product Portfolio
  60. 7.10.5 Signalway Antibody LLC Recent Developments
  61. 7.11 United States Biological
  62. 7.11.1 United States Biological Company Information
  63. 7.11.2 United States Biological Business Overview
  64. 7.11.3 United States Biological Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  65. 7.11.4 United States Biological Alpha-1-Antitrypsin Antibody Product Portfolio
  66. 7.11.5 United States Biological Recent Developments
  67. 7.12 Merck
  68. 7.12.1 Merck Company Information
  69. 7.12.2 Merck Business Overview
  70. 7.12.3 Merck Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merck Alpha-1-Antitrypsin Antibody Product Portfolio
  72. 7.12.5 Merck Recent Developments
  73. 7.13 Thermo Fisher Scientific
  74. 7.13.1 Thermo Fisher Scientific Company Information
  75. 7.13.2 Thermo Fisher Scientific Business Overview
  76. 7.13.3 Thermo Fisher Scientific Alpha-1-Antitrypsin Antibody Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Thermo Fisher Scientific Alpha-1-Antitrypsin Antibody Product Portfolio
  78. 7.13.5 Thermo Fisher Scientific Recent Developments
8 North America
  1. 8.1 North America Alpha-1-Antitrypsin Antibody Revenue (2021-2032)
  2. 8.2 North America Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 8.2.1 North America Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026)
  4. 8.2.2 North America Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032)
  5. 8.3 North America Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032)
  6. 8.4 North America Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  7. 8.4.1 North America Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026)
  8. 8.4.2 North America Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032)
  9. 8.5 North America Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032)
  10. 8.6 North America Alpha-1-Antitrypsin Antibody Revenue by Country
  11. 8.6.1 North America Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026)
  13. 8.6.3 North America Alpha-1-Antitrypsin Antibody Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Alpha-1-Antitrypsin Antibody Revenue (2021-2032)
  2. 9.2 Europe Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 9.2.1 Europe Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026)
  4. 9.2.2 Europe Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032)
  5. 9.3 Europe Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032)
  6. 9.4 Europe Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  7. 9.4.1 Europe Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026)
  8. 9.4.2 Europe Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032)
  9. 9.5 Europe Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032)
  10. 9.6 Europe Alpha-1-Antitrypsin Antibody Revenue by Country
  11. 9.6.1 Europe Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026)
  13. 9.6.3 Europe Alpha-1-Antitrypsin Antibody Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Alpha-1-Antitrypsin Antibody Revenue (2021-2032)
  2. 10.2 China Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 10.2.1 China Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026)
  4. 10.2.2 China Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032)
  5. 10.3 China Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032)
  6. 10.4 China Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  7. 10.4.1 China Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026)
  8. 10.4.2 China Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032)
  9. 10.5 China Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alpha-1-Antitrypsin Antibody Revenue (2021-2032)
  2. 11.2 Asia Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 11.2.1 Asia Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026)
  4. 11.2.2 Asia Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032)
  5. 11.3 Asia Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032)
  6. 11.4 Asia Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  7. 11.4.1 Asia Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026)
  8. 11.4.2 Asia Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032)
  9. 11.5 Asia Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032)
  10. 11.6 Asia Alpha-1-Antitrypsin Antibody Revenue by Country
  11. 11.6.1 Asia Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026)
  13. 11.6.3 Asia Alpha-1-Antitrypsin Antibody Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alpha-1-Antitrypsin Antibody Revenue (2021-2032)
  2. 12.2 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Type (2027-2032)
  5. 12.3 SAMEA Alpha-1-Antitrypsin Antibody Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Application (2027-2032)
  9. 12.5 SAMEA Alpha-1-Antitrypsin Antibody Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country
  11. 12.6.1 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Alpha-1-Antitrypsin Antibody Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst